scholarly article | Q13442814 |
P50 | author | Linda R. Watkins | Q4291013 |
Peter M. Grace | Q42415682 | ||
Keith A Strand | Q57178002 | ||
Lisa C Loram | Q116996280 | ||
Debra Berkelhammer | Q125308041 | ||
Bryce Skarda | Q125308452 | ||
P2093 | author name string | Steven F Maier | |
Frederick R Taylor | |||
Amanda Ellis | |||
Melissa Bowlin | |||
P2860 | cites work | Prior laparotomy or corticosterone potentiates lipopolysaccharide-induced fever and sickness behaviors | Q38887170 |
Effects of prior stress on LPS-induced cytokine and sickness responses | Q40572219 | ||
Intrathecal morphine attenuates recovery of function after a spinal cord injury | Q41895164 | ||
The impact of morphine after a spinal cord injury | Q41977639 | ||
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses | Q42381161 | ||
The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses | Q42465510 | ||
Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming | Q42571646 | ||
The involvement of glial cells in the development of morphine tolerance | Q43542087 | ||
Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide | Q44180117 | ||
Trigeminal transition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats | Q46817289 | ||
Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain | Q47599610 | ||
Prior stressor exposure sensitizes LPS-induced cytokine production. | Q48561445 | ||
Function and phenotype of microglia are determined by toll-like receptor 2/toll-like receptor 4 activation sequence. | Q54472535 | ||
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. | Q55179706 | ||
A novel animal model of graded neuropathic pain: Utility to investigate mechanisms of population heterogeneity | Q57824728 | ||
A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats | Q58876476 | ||
An improved method for assessing mechanical allodynia in the rat | Q73289147 | ||
From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
Pathological and protective roles of glia in chronic pain | Q24646738 | ||
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia | Q24650758 | ||
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences | Q28274052 | ||
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) | Q28288846 | ||
A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine | Q28580405 | ||
Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 | ||
Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. | Q30326539 | ||
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy | Q33936995 | ||
Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation | Q33996310 | ||
Trigeminal subnucleus caudalis: beyond homologies with the spinal dorsal horn | Q34078116 | ||
Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo | Q34117698 | ||
Memory impairments in healthy aging: Role of aging-induced microglial sensitization | Q34368916 | ||
Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids | Q34399068 | ||
Atypical inflammation in the central nervous system in prion disease | Q34668016 | ||
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia | Q35122783 | ||
Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation | Q35194571 | ||
Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity | Q35762455 | ||
Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist | Q35818737 | ||
Toll-like receptors in chronic pain | Q35830682 | ||
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia | Q35871035 | ||
Morphine activates neuroinflammation in a manner parallel to endotoxin | Q35924760 | ||
Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids | Q36686688 | ||
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction | Q36741881 | ||
Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines | Q37218585 | ||
The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain | Q37240358 | ||
Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation | Q37327069 | ||
Neuropathic pain: a maladaptive response of the nervous system to damage | Q37401775 | ||
Targeting Toll-like receptors: emerging therapeutics? | Q37727910 | ||
The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines | Q37792573 | ||
Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation | Q37812669 | ||
Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain | Q37865609 | ||
Role of glia in orofacial pain | Q37867904 | ||
A brief comparison of the pathophysiology of inflammatory versus neuropathic pain | Q37887452 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphine | Q81225 |
inflammation | Q101991 | ||
P304 | page(s) | 1256-1264 | |
P577 | publication date | 2012-08-10 | |
P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
P1476 | title | Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy | |
P478 | volume | 26 |
Q39213778 | Activation of CXCL10/CXCR3 signaling attenuates morphine analgesia: involvement of Gi protein |
Q94052431 | Astrocytic hypertrophy in the rat ventral tegmental area following chronic morphine differs with age |
Q33721292 | Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners. |
Q37291190 | Cytokines, chaperones and neuroinflammatory responses in heroin-related death: what can we learn from different patterns of cellular expression? |
Q43076075 | Glial and neuroinflammatory targets for treating substance use disorders |
Q39402180 | Heroin-piracetam mixture: Suggested mechanisms of action and risks of misinterpretation for drug users |
Q38218630 | Interactions between glia, the immune system and pain processes during early development |
Q42612548 | Mast cell activation contributes to sickle cell pathobiology and pain in mice |
Q88557397 | MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats |
Q93000944 | Morphine Exacerbates Postfracture Nociceptive Sensitization, Functional Impairment, and Microglial Activation in Mice |
Q39494983 | Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury |
Q64271611 | Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitization |
Q37021812 | Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation |
Q38395503 | Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain |
Q38318330 | Opioid and chemokine receptor crosstalk: a promising target for pain therapy? |
Q27021477 | Opioid-induced central immune signaling: implications for opioid analgesia |
Q91828504 | Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats |
Q33925677 | Pathological pain and the neuroimmune interface |
Q47874540 | Protraction of neuropathic pain by morphine is mediated by spinal damage associated molecular patterns (DAMPs) in male rats |
Q38287403 | Renin-angiotensin system in pain: existing in a double life? |
Q88213582 | Repeated Morphine Prolongs Postoperative Pain in Male Rats |
Q42415616 | Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as a measure of hind paw-evoked pain |
Q49384858 | The dark side of opioids in pain management: basic science explains clinical observation |
Search more.